UNSPSC 51182432: Minodronic acid

This classification denotes a bone resorption inhibitor with the molecular formula C9H12N2O7P2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 40SGR63TGL, chemically known as 1-hydroxy-2-(imidazo(1,2-a)pyridin-3-yl)ethane-1,1-bisphosphonic acid monohydrate but generally known as minodronic acid, which bears US NIH Compound Identifier 130956. European Medicines Agency schedules Minodronic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08981MIG.

UNSPSC 51182432 Minodronic acid is a Commodity code that represents pharmaceutical active ingredients and finished-dose medications procured through cooperative purchasing agreements by state and local health systems, departments, and facilities. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued a Request for Proposal on January 20, 2026 to establish multiple contracts for generic multi-source pharmaceuticals and over-the-counter products distributed across participating state and local government facilities in Minnesota and Oregon. Under this code, state and local procurement bodies purchase finished pharmaceutical products with specific National Drug Codes (NDCs), requiring vendors to supply detailed product specifications including generic descriptions, strength, dosage form, trade names, packaging configurations, and manufacturing locations. Products must be sourced through authorized wholesalers (AmerisourceBergen Drug Corporation / Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) and comply with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA). Vendors must carry substantial commercial general liability, network security and privacy liability, and professional liability insurance, and accept performance penalties ranging from $200 to $1,500 per violation for issues such as late reporting or missed onboarding timelines.

MMCAP's RFP represents the primary recent state and local activity under this code, with proposals due March 26, 2026, a cutoff date for questions of February 18, 2026, and contract awards effective July 1, 2026 for an initial two-year term with optional extensions at MMCAP's discretion. Evaluation criteria weight price competitiveness at 75 percent, fixed pricing for the contract term at 10 percent, compliance with administrative fee data formats at 5 percent, EDI capability at 5 percent, and agreement to a 3 percent administrative fee at 5 percent. Vendors must maintain contractual relationships with at least two of the three authorized wholesalers and demonstrate pricing flexibility through flat price, net price formats (NF30, NF60, NF90), or WAC-minus structures. No specific award values or budget ranges are disclosed in the solicitation materials, though the administrative fee structure and multi-award potential suggest significant volume across the participating state and local member base.